Do cHEK2 germline mutations correlate with recurrence rate in patients with superficial bladder cancer?
The results indicate that patients with CHEK2 mutation may present poorer clinical course with several recurrences of SBC. It also suggests a possible prognostic significance of CHEK2 analysis in identifying patients with higher risk of recurrence, which may imply more aggressive treatment modalities or necessity of modified follow-up schedule.
Single-step LC+LTCBDE using an ultrathin choledochoscope may provide better outcomes in patients with gallstones and suspected choledocholithiasis.